OR WAIT null SECS
Accurately targeted immunotherapies through reliable neoantigen recognition enable personalized medicine development.
Activation and expansion are essential for success in both autologous and allogeneic therapies.
Continuous manufacturing and a quality-by-design development approach are a natural fit.
November 03, 2021
The researchers will use 3D printing to design novel flow reactors and static mixers.
Alternative drug delivery approaches are promising, but due to their complexity, they need to be sufficiently justified.
Advances in simulation and the development of digital twins.
November 02, 2021
SEDDS and SMEDDS improve solubility and permeability while expanding efficacy and applicability.
October 29, 2021
Novavax has filed its COVID-19 vaccine for authorization in the UK and Australia.
The $691 million deal will see Vertex use Mammoth’s systems to discover and develop in-vivo gene-editing therapies.
The National Institutes of Health (NIH), FDA, and fifteen private organizations are partnering together to form the Bespoke Gene Therapy Consortium.
Ajinomoto and its subsidiary company, Ajinomoto Genexine, have partnered with Insilico Biotechnology to accelerate and improve process development and production of biologics using digital twin technology.
October 22, 2021
Spectrum Chemical scientists give a shout-out to 10 chemicals impacting quality of life in conjunction with National Chemistry Week.
Crystec and Biosidus have joined forces to enhance the delivery and performance of biotherapeutics.